Myasthenia gravis treatment in the elderly presents with a significant iatrogenic risk: a multicentric retrospective study.

Jean-Baptiste ChansonFrançoise BouhourAnne-Catherine Aubé-NathierMartial MallaretChristophe VialAurélien HacquardPhilippe PetiotMarco SpinazziAleksandra Nadaj-PaklezaAndoni Echaniz-Laguna

Published in: Journal of neurology (2023)

This retrospective study demonstrates MG in the elderly presents with a significant iatrogenic risk, including fatal immunosuppressant-related infections.

Keyphrases

myasthenia gravis
middle aged